Journal article
Evaluation and Management of Glucocorticoid-Induced Adrenal Insufficiency in IBD: An Expert Opinion
Abstract
BACKGROUND AND AIMS: Glucocorticoid-induced adrenal insufficiency (GC-AI) is a potentially life-threatening side effect of glucocorticoid therapy. Currently, there is no consensus on monitoring and treating GC-AI in inflammatory bowel disease (IBD) patients. This systematic review and meta-analysis aimed to determine the prevalence of GC-AI in IBD patients following glucocorticoid use. Additionally, a Delphi panel was conducted to develop …
Authors
Law CCY; Sheskier R; Viera-Feliciano N; Delgado-Nieves A; Seth S; Hanžel J; Ma C; Colombel J-F; Levine AC; Spencer EA
Journal
Inflammatory Bowel Diseases, Vol. 31, No. 11, pp. 3077–3092
Publisher
Oxford University Press (OUP)
Publication Date
June 30, 2025
DOI
10.1093/ibd/izaf136
ISSN
1078-0998